CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −2,949 | $24.76 | $73K | 918,200 |
| 2026-02-26 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −1,168 | $24.76 | $29K | 378,027 |
| 2026-02-24 | Kim Paul CFO and Treasurer | Grant or award | +5,721 | 333,206 | ||
| 2026-02-24 | Kim Paul CFO and Treasurer | Grant or award | +14,926 | 348,132 | ||
| 2026-02-24 | Kim Paul CFO and Treasurer | Grant or award | +26,673 | 374,805 | ||
| 2026-02-24 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −3,241 | $23.09 | $75K | 371,564 |
| 2026-02-24 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −8,456 | $23.09 | $195K | 363,108 |
| 2026-02-24 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −15,095 | $23.09 | $349K | 348,013 |
| 2026-02-24 | Kim Paul CFO and Treasurer | Grant or award | +31,182 | 379,195 | ||
| 2026-02-24 | Xie Jian President and COO | Grant or award | +5,862 | 337,245 | ||
| 2026-02-24 | Xie Jian President and COO | Grant or award | +15,299 | 352,544 | ||
| 2026-02-24 | Xie Jian President and COO | Grant or award | +27,341 | 379,885 | ||
| 2026-02-24 | Xie Jian President and COO | Shares withheld for taxes | −3,163 | $23.09 | $73K | 376,722 |
| 2026-02-24 | Xie Jian President and COO | Shares withheld for taxes | −8,254 | $23.09 | $191K | 368,468 |
| 2026-02-24 | Xie Jian President and COO | Shares withheld for taxes | −14,751 | $23.09 | $341K | 353,717 |
| 2026-02-24 | Xie Jian President and COO | Grant or award | +31,962 | 385,679 | ||
| 2026-02-24 | Gao Hanlin Chief Scientific Officer | Grant or award | +4,891 | 956,047 | ||
| 2026-02-24 | Gao Hanlin Chief Scientific Officer | Grant or award | +12,762 | 968,809 | ||
| 2026-02-24 | Gao Hanlin Chief Scientific Officer | Grant or award | +22,806 | 991,615 | ||
| 2026-02-24 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −2,489 | $23.09 | $57K | 989,126 |
Page 3 of 15 · 300 trades